RecallHawk
Class II Recall

The Everest Bipolar Cutting Forceps are intended to be passed through a 5-mm or 10-mm cannula, depending on the model/ou

Olympus Corporation of the Americas

Summary

The FDA issued a Class II for The Everest Bipolar Cutting Forceps are intended to be passed through a 5-mm or by Olympus Corporation of the Americas. Reason: Fractures and breakages in packaging trays and Tyvek covers, which may result in a sterility breach.

Details

Source

Device Recall

External ID

Z-2541-2024

Action Date

2024-08-14

Status

Ongoing

Category

device

Product Description

The Everest Bipolar Cutting Forceps are intended to be passed through a 5-mm or 10-mm cannula, depending on the model/outer diameter size of the forceps. Coagulation is achieved using electrosurgical energy under visualization. The device is to be used with bipolar outputs of compatible generators. The forceps' jaws are electrically isolated from each other enabling one jaw to act as a return electrode, eliminating the need for a return pad. To transect tissue, a cutting blade is actuated and moves between the electrode jaws. The connections (bipolar electrical signal) to the forceps are through either a hardwired cable (model 3006) or a connector at the bottom of the handle (models 3000 and 3005). The device includes mechanisms (switches and triggers) to provide coagulation using the bipolar electrical energy that reaches the forceps. The forceps are positioned in the desired location for grasping, coagulation, and transection of tissue. The anatomical structure to be coagulated is placed between the open forceps jaws, and once the Forceps Grip trigger is squeezed, the forceps' jaws are closed onto tissue, followed by coagulation. The device includes a blade that is mechanically advanced to perform tissue cutting as needed.

Lot/Code Info: UDI: 00821925035881 Batch Number: FR137723 FR139935 FR141534 FR145203 FR157420 FR165250 FR176934 FR179541 FR197926 FR204443 FR206007 FR207123 FR214689 FR215012 FR215026 FR246906 FR261731 FR297010 FR305512 FR308131 FR335638 FR335650 FR378737 FR390629 FR397748 PW308683

Quantity Affected: 6985 units

Reason for Recall

Fractures and breakages in packaging trays and Tyvek covers, which may result in a sterility breach

Distribution

Worldwide distribution - US Nationwide and the countries of CA, DE, AU, SG, KR.

Type: Voluntary: Firm initiated

Recall Initiated: 2024-07-01

Company

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 158 device recalls issued in the same week, part of 413 device-related FDA actions this month.

Olympus Corporation of the Americas has 334 FDA actions in our database, including 334 recalls.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Olympus Corporation of the Americas) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Olympus Corporation of the Americas have FDA actions?

Olympus Corporation of the Americas has 334 FDA actions in our database, including 334 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-2541-2024" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions